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INTRODUCTION 
Hypertensive disorders complicating pregnancy form one of the 
components of the deadly triad along with hemorrhage and infection that 
results in maternal deaths. The normal  pregnancy  is  a  result  of  a  
complex  series of changes in the vascular anatomy of the mother, 
principally in the uterine perfusion that is fundamental for the pregnancy 
success. With the implantation of the fertilized ovum in the uterine cavity, 
the arterial system that irrigates the endometrium and the subjacent 
myometrium undergoes a series of changes which lead to the uteroplacental 
circulation. Such changes in the arterial system are a result of the decidua 
invasion by the trophoblast. 
    Although the presentation of hypertensive disorders of pregnancy differs 
throughout the world , it remains a major contributor to maternal and fetal 
compromise. The addition of Doppler flow studies of maternal and fetal 
vessels has provided a tool where the physiology of maternal fetal unit can 
be assessed. Use of fetal Doppler has become common in evaluation and 
management of pregnancy associated with intrauterine growth restriction 
and red cell isoimmunisation. Commonly assessed are Uterine artery, 
Umblical artery and Middle cerebral artery Doppler wave forms. 
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Persistance of uterine artery notching beyond 24 weeks gestation and > 95 th 
percentile of pulsatility index of uterine artery Doppler combined together 
provide greater predictive value for detection of pregnancy induced 
hypertension. Early detection of PIH helps to treat earlier and to prevent 
maternal and fetal morbidity and mortality. 
In FASTER study, large prospective observation study used uterine 
artery Doppler wave forms for prediction of PIH. Recent meta analysis 
concluded that Pulsatility index and uterine artery notching had best 
predictive value for diagnosis of pregnancy induced hypertension . 
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AIMS AND OBJECTIVES 
 
1) To study the role of Doppler ultrasound in prediction of pregnancy 
induced hypertension . 
2)  Comparison of  efficacy of Doppler in the prediction of pregnancy 
induced hypertension over other risk factors . 
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REVIEW OF LITERATURE 
 
        Hypertensive disorders of pregnancy is one of the important and 
unsolved emerging problem in the sea of obstetrics. kaunitz et al 1 mentioned 
that 20% of maternal mortality from 1975 to 1977 were related to 
hypertensive disorders associated with hypertension. Pregnancy induced 
hypertension has a progressive course. Process of continuous deterioration is 
stopped finally only by delivery. It is important to detect disease in early 
stages and appropriate management in early stages may improve the 
outcome for both mother and fetus. 
     Hypertensive disorders associated with 5 to 10% of all pregnancies and 
contribute to maternal mortality and morbidity. Various studies has been 
done these years for early detection and prevention of developing 
devastating complications. 
Martin et al (2) mentioned that preeclampsia is found in 3.9% of all 
pregnancies. According to WHO reviews 16% of the maternal deaths were 
due to hypertensive disorders (3). More than half of the hypertension related 
deaths are preventable (4). 
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CLASSIFICATION OF PREGNANCY INDUCED HYPERTENSION : 
Classification was given by working group of National high blood pressure 
education programme (NHBPEP-2000). 
Updated version was proposed by American college of obstetricians and 
gynaecologists (2013). 
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TYPES OF HYPERTENSIVE DISORDERS : 
1) Gestational hypertension – BP > 140/90 mmHg after 20 weeks in 
previously normotensive women. Resolves 12 weeks postpartum. 
2) Preeclapmsia and eclampsia syndrome  
3) Chronic hypertension 
4) Preeclampsia superimposed on chronic hypertension. 
Definition proposed as follows (5) : 
HYPERTENSION : 
1)  Diastolic BP of  greater than or equal to 90 mmHg 
     Systolic BP of  greater than or equal to 140 mmHg 
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2) Rise of diastolic BP of atleast 15 mmHg ,Systolic BP of atleast 
 30 mmHg  if the patient’s previous BP is known. 
3) Blood pressure should be measured an atleast 2 occasions 6 
 hours or more apart. 
4)  Delta hypertension: Sudden rise in mean arterial pressure later 
in pregnancy may also signify preeclampsia even if BP is less 
than 140/90 mmHg (6).  
Mean arterial pressure = Diastolic Bp +1/3 pulse  pressure. 
              METHODS TO MEASURE BLOOD PRESSURE(48) 
 Blood pressure should  be measured  after a ten minutes or   longer  
period of  rest to alleviate anxiety. 
 
 Blood pressure should be measured with appropriate size cuff. 
 
 Length of the cuff must be 1.5 times the upper arm circumference. 
 
 Cuff bladder should encircle 80 % or more of the arm. 
 Blood pressure should be measured in an upright posture with the 
right arm supported in horizontal position at the level of heart. 
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 Large size cuff should be used for obese patients. 
 
 Falsely low as much as 15 mmHg has been documented when patient 
lie on their left side and blood pressure taken on their right arm. 
 
 Diastolic blood pressure should be measured according to the 
disappearance of  Korotkoff  phase 5 . 
 
 Korotkoff phase 5 is better and more reproducible than korotkoff 
phase 4  ( muffling ) . 
 
 In case when korotkoff  phase  5 is absent we can take korotcoff 4 as 
cut of point. 
 
 Automated system we regularly use in well developed infrastructure 
setup are somewhat unreliable in severe preeclampsia. Because there 
is a possibility of under record of blood pressure especially systolic 
blood pressure . 
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PREECLAMPSIA : 
1) Hypertension with protenuria , induced by  pregnancy after 20 
weeks of gestation . 
PROTEINURIA : 
1) 300mg/L or more of protein in 24 hour urine collection. 
2) 1g or more /L . 
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WEIGHT GAIN: Weight gain of 5 lb(2.28kg) or more in 1 week . 
 
ECLAMPSIA: 
1)  Convulsion in women whose condition also meets criteria for 
 preeclampsia . 
2)  Coincidental neurological disease are ruled out. 
 
CHRONIC HYPERTENSION : 
1) Persistent hypertension developed less than 20 weeks. 
2)  Persistent hypertension beyond  12 weeks postpartum. 
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SUPERIMPOSED PREECLAMPSIA : 
Development of preeclampsia in a women with chronic hypertension. 
DIAGNOSTIC CRITERIA FOR PREGNANCY ASSOCIATED 
HYPERTENSION (ACOG 2013) : 
1. GHT BP> 140/90mmHg in previously normotensive 
women . 
2. Proteinuria >300mg/24 hr Protein creatinine ratio >0.3 
Dipstick 1+ persistent 
3. Thrombocytopenia Platelet < 100,000/microL 
4. Renal insufficiency Creatinine >1.1mg/dl (or) Doubling of base line 
5. Liver involvement Sr.transaminase level twice normal 
6. Cerebral symptoms Head ache, visual disturbances, convulsions. 
 
 
  
13 
 
INDICATORS OF SEVERITY OF HYPERTENSIVE DISORDERS (4) 
  NON SEVERE SEVERE 
1. Systolic BP <160 >/= 160 
2. Diastolic BP <110 >/= 110 
3. Proteinuria NOT INCLUDED 
IN 
SEVERITY  
CLASSIF 
4. Headache - + 
5. Visual disturbances - + 
6. Right hypochondrial pain - + 
7. oliguria - + 
8. sr.creatinine Normal Elevated 
9. Trombocytopenia - + 
10. sr.transaminase Elevated Markedly elevated 
11. Pulmonary edema - + 
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INCIDENCE : 
Incidence of pregnancy induced hypertension depends on race, ethnicity, 
genetic predisposition, seasonal influences (7) . 
Incidence among nulliparous women is about 3-10 %(8). 
Incidence in singleton pregnancy is 5% , while in twin pregnancy it is about 
13% (9). 
RISK FACTORS: 
 Young women are more prone to develop preeclampsia. 
 Nulliparity 
 Older women are more prone to develop chronic hypertension with 
superimposed preeclampsia. 
 Obesity 
 Multi fetal gestation 
 Metabolic syndrome 
 Hyperhomocystenemia 
 Kraus et al mentioned that smoking upregulates placental 
adrenomedullin expression which inturn regulates volume 
homeostasis (10). 
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 History of preeclampsia in previous pregnancy are at greater risk of 
developing preeclampsia in present pregnancy also. (11). 
ETIOPATHOGENESIS : 
1. When patient is exposed to chorionic villi for the first time. 
2. Genetically predisposed 
3. Exposed to abundance of chorionic villi as in multiple pregnancy and 
in hydatidiform mole. 
4. Inflammation/activation of endothelial cells. 
30% incidence in women with an extrauterine pregnancy more than 18 
weeks gestation .Eventhough chorionic villi is essential it need not to be 
intrauterine . 
Ness & Roberts quotes “ 2 stage disorder “ which includes maternal and 
fetal preeclampsia . 
According to Redman & co workers pathogenesis includes: 
1) STAGE 1 : Faulty endovascular trophoblastic remodeling. 
2)  STAGE 2 : Clinical syndrome 
 Manifest by endothelial cell activation/inflammation 
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ETIOLOGY : 
1) ABNORMAL TROPHOBLASTIC INVASION : 
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NORMAL IMPLANTATION : Extensive remodeling of spiral arterioles 
within the deciduas basalis. Endovascular trophoblasts replace the vascular 
endothelial and muscular linings. The final result is that we get a vessel with 
greater diameter. 
PREECLAMPSIA : 
 Incomplete trophoblastic invasion. 
 Endothelial damage, proliferation of myointimal cell, medial 
necrosis(16). 
 Vascular lesions including spiral arteriole narrowing, atherosis and 
infarcts (17).  
 Decreased soluble anti angiogenic growth factors (18). 
 Increased risk of later atherosclerosis and cardiovascular disease (19). 
2) IMMUNOLOGICAL FACTORS : 
 Inherited human leukocyte antigen. 
 Natural killer cell receptor 
 Sharing of susceptibility genes with diabetes and hypertension 
 Immune maladaptation 
  Reduced amounts of immunosuppressive nonclassic HLA. 
 Increased placental oxidative products. 
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3) ENDOTHELIAL CELL ACTIVATION : 
 Reactive oxygen species and fee radicals. 
 Cytokines such as TNF alpha and interleukins may contribute to 
oxidative stress 
 Extreme activated state of leukocytes in maternal circulation. 
 
4) NUTRITIONAL FACTORS : 
 Trials showed that supplementation of antioxidant vitamin C & E has 
no additional benefits. 
 Diet containing fruits and vegetables with antioxidant activity 
associated with decrease in BP. 
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5) GENETIC FACTORS : 
GENE POLYMORPHISM FUNCTION AFFECTED 
Leiden mutation Factor 5 
MTHFR(C6771) Methylene tetrahydtrofolate reductase 
F2(G20210A) Prothrombin factor 2 
ACE Angiotensin converting enzyme 
SERPINE 1 Serine peptidase inhibitor 
LPL Lipoprotein lipase 
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PATHOGENESIS : 
1) VASOSPASM :  
 Ultrastructural changes in subendothelial region of resistance arteries 
in preeclamptic women(20). 
 Markedly attenuated blood volume(21). 
 Increase vasoconstriction. 
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PATHOGENESIS : 
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ENDOTHELIAL CELL INJURY : 
 Increased circulating endothelial cells in the peripheral blood (22). 
 Increased circulating endothelial microparticles(23). 
 Increased sensitivity to vasopression. 
 Damaged endothelial cells may produce substances that promote 
coagulation (24). 
 Increased reactivity to infused norepinephrine and angiotensin 2 (25). 
 Decreased prostaglandin I2 : Thromboxane A2 ratio. 
 In patient who develop pre eclampsia later have endothelial changes 
visible as early as 22 weeks gestation.(26). 
 Decreased nitric oxide synthase expression (27). 
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FEATURES AND COMPLICATIONS OF PIH:
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EFFECTS OF PREECLAMPSIA AND ECLAMPSIA ON MOTHER 
AND FETUS: 
o CARDIO VASCULAR SYSTEM  
o HORMONAL EFFECTS 
o HAEMOTOLOGICAL EFFECTS 
o EFFECTS ON ORGANS 
o EFFECTS  ON FETUS 
 
1) EFFECTS ON CARDIOVASCULAR SYSTEM : 
 
 Blood pressure is a product of cardiac output and total peripheral 
resistance. 
 There is an increase in cardiac output in first trimester, peak of 30 to 
50 % above non pregnant levels in the middle of second trimester and 
then the value is maintained in the rest of the pregnancy(42). 
 In case of pregnancy induced hypertension the increase in cardiac 
output is maintained and rises further more. 
 In normal pregnancy there is decrease in peripheral vascular 
resistance by 25%. 
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 In case of pregnancy induced hypertension there is considerable 
increase in total peripheral resistance, which is the main cause of raise 
in the blood pressure (43). 
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2)  HORMONAL EFFECTS: 
 
 
 Alterations in vascular sensitivity to endogenous hormones like 
Angiotensin 2, catecholamines and vasopressin causes increase in 
vascular resistance in the blood vessel vasculature. This in turn causes 
increase in blood pressure.  
 
 In pregnancy induced hypertension there is increase in vascular 
reactivity to pressor agents (44). 
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 In about 17 weeks of gestation abnormal sensitivity to pressor agents 
develop. 
 
 Prostacyclin is produced by the vascular endothelium. It is a potent 
vasodilator and anti platelet aggregant. 
 
 
 Thromboxane A2 is produced by platelets and trophoblast. It is a 
potent vasoconstrictor and platelet aggregator. 
 
 In pregnancy induced hypertension there is alteration in ratio of 
Thromboxane A2 and prostacyclin. 
 
 
 6 keto PGF1 alpha, a metabolite of prostacyclin found in maternal 
vessels,placenta and umbilical vessels in the patients with pregnancy  
induced hypertension. 
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3) HAEMATOLOGICAL CHANGES : 
 In normal pregnant women there is increase in about 50 % of blood 
volume at the end of second trimester. There is more increase in 
plasma than erythrocyte which inturn leads to physiological anaemia 
of pregnancy. 
 In pregnancy induced hypertension there in decreased expansion of 
blood volume of about 16 % (45) 
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 There is profound haemoconcentration  which leads to decrease in 
regional perfusion. 
 There is increase in hematocrit values in severe preeclampsia. 
 Injury to the endothelial lining causes microangiopathic hemolysis . 
 In peripheral smear there may be anaemia, thrombocytopenia and 
fragmented red blood cells . 
 Increase in fibronectin 
 Decrease in antithrombin 3and alpha 2 antiplasmin. 
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                              EFFECTS ON ORGANS      
1) KIDNEY : 
 In normal pregnancy there is increase in renal blood flow and 
glomerular filtration rate. 
 In pregnancy induced hypertension there is a decrease in renal 
perfusion by 20 5 and decrease in glomerular filtration rate by 
32%(46) 
 Characteristic microscopic features in PIH are as follows 
1) Capillary endothelial swelling 
2) Deposition of fibrinogen derivatives 
3) Glomerular capillary endotheliosis 
4) Swollen endothelial cells blocking the capillary lumens. 
Resolution of the above changes occur several weeks after delivery.  
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2) LIVER : 
 
 In HELLP syndrome there is hemolysis, elevated liver enzymes 
and low platelets. 
 Characteristic feature is periportal haemorrhagic necrosis around 
the periphery of the liver lobule. 
 Subcapsular hematoma 
 Haemorrhage under liver capsule may lead to life threatening 
intraperitoneal bleed. 
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3) BRAIN : 
 Recent study shows that there is an increase in cerebral vascular 
resistance in pregnancy induced hypertension. 
 But there is normal cerebral blood flow and cerebral oxygen 
metabolism in PIH patients(47) 
 One third of the patients died due to cerebral haemorrhage ranging 
from petechiae to haematoma. 
 In electro encephalogram there may be a transient change in 
patients who have eclamptic seizures. 
 Most common hypodense cortical areas correspond to 
haemorrhage and local edema in preeclampsia.
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4) Retina : 
 
GRADES OF HYPERTENSIVE RETINOPATHY : 
GRADE 1  :   Slight or modest narrowing of the retinal vessels with an  
Arterial: venous ratio > 1:2                                      
GRADE 2 :  Modest to severe narrowing of retinal arteries with an  
Arterial: venous ratio <1:2 
GRADE 3 :  Soft exudates and flame shaped hemorrhages 
GRADE 4  :  Grade 3 changes and bilateral optic nerve edema 
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Because of all the above risk to develop hypertensive retinopathy all 
patients with pregnancy induced hypertension should undergo regular 
ophthalmic assessment in speciality clinic. 
EFFECTS ON FETUS : 
 Intrauterine growth retardation 
 Preterm labour 
 Utero placental insufficiency 
 Oligohydramnios 
 High risk of abruption placenta and hence by increasing risk of 
intrauterine death of the fetus. 
The following screening tests are done for prediction of pre eclampsia : 
1) Doppler ultrasound : Finding high resistance index in the second 
trimester 
2) Presence of diastolic notch at 24 weeks gestation 
3) Absence of end diastolic frequencies 
4) Average mean arterial pressure : In second trimester >90 mmHg may 
predict pregnancy induced hypertension. 
5) Fetal DNA: Detection of free fetal DNA in maternal serum in early 
pregnancy may be a predictive value 
36 
 
6) Roll over test – screening done between 28 to 32 weeks. Blood 
pressure is measured with the patient on her side first and then the 
patient is asked to roll over on her back to check the blood pressure 
once again. An increase in 20 mmHg in diastolic pressure from side to 
back position indicates positive roll over test. 
7) Angiotensin sensitivity test 
8) Isometric exercise test 
9) Fibronectin 
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DOPPLER STUDY – AN OUTLINE 
Recently Doppler study has become essential in routine antenatal care 
checkup. 
BASIC PRINCIPLES : 
Measurement of movement of blood flow through the vessel. USG 
scanners transmit series of pulses to detect the movement of blood. Echoes 
from stationary tissue are same from pulse to pulse (28). 
             Echoes from moving scatterers exhibit slight difference in time for 
signal to be returned to receiver. Difference can be measured interms of 
phase shift from which Doppler frequency is obtained (29). 
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BASIC PRINCIPLES IN DOPPLER STUDY: 
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Doppler scan depends on : 
1) Blood velocity : As velocity increases there is increase in Doppler 
frequency . 
2)  USG frequency : Higher USG frequency give increase in doppler 
velocity . 
3) Angle of insonation :   
   When Doppler wave beam is more towards the flow direction, 
frequency of Doppler increases. Angle between the beam and 
direction of flow is called theta. 
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All Doppler USG instrument have special equipment to remove low 
frequency Doppler signals resulting from tissue movement. 
CONTINUOUS WAVE DOPPLER : 
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PULSE WAVE DOPPLER : 
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FACTORS AFFECTING COLOUR FLOW IMAGES : 
1) Transmitted power to tissue. 
2) Sensitivity to flow signals 
3) FREQUENCY : Trades penetration for sensitivity and resolution . 
4) AREA OF INVESTIGATION : Larger area decreases the frame 
rate  
5) FOCUS : Colour flow image optimized at focal zone 
INDICES USED(31) : 
1) RESISTANCE INDEX(POURCELOT’S INDEX ): S-D/S 
2) SYSTOLIC/DIASTOLIC RATIO (A/B ratio ) 
3) PULSATILITY INDEX(GOSLING INDEX) : S-D/A 
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INDICES USED IN DOPPLER STUDY 
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CONTINUOUS WAVE DOPPLER : 
 
 Continuous wave Doppler uses continuous emission and reception 
of sound. 
 Signals returning from the insonated tissues overlap and are not 
distinguished as separate entities. 
 If the sound beam crosses more than one vessel, all of them will be 
displayed simultaneously, and the operator will be unable to 
determine with reasonable entity from which vessel the signal is 
coming from. 
 In regards to umbilical vessels, this is not a problem since these 
vessels are unique in maternal body and only during pregnancy. 
 If we add duplex imaging techniques , it improves our results. 
 Only two vessels use this method : 
1) Portable doptone 
2) Fetal heart rate  monitoring equipment 
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PULSED WAVE DOPPLER : 
 It has improved our discriminatory abilities substantially. 
 Emits pulses of sound only for a fraction of time and receives the 
returning signals the rest of the time. 
 Each returning signal is recognized by its timing and thus the 
system defines the depth of structure. 
 With this we can see the vessel or the intermediate region and then 
the place the PW Doppler range gate over this area. 
  
ARTERIAL DOPPLER 
Fetal arterial system has been extensively studied to determine if 
abnormal wave forms identify fetuses at risk for perinatal mortality. We are 
supposed to study the following : 
                1) Uterine artery 
                2) Umblical artery 
                3) Middle cerebral artery 
                4) Thoracic aorta 
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1) UTERINE ARTERY: 
 Uteroplacental circulation can be assessd by means of Doppler 
ultrasonography. 
 Uterine artery notching seen in early trimester is a normal 
phenomenon. 
 As the gestational age increases there is a drop in uterine artery SD 
ratio. 
 Abnormal uterine artery Doppler velocity is defined as an average of 
S/D ratio greater than 2.6 and if there is diastolic notching. 
 Changes in the flow pattern of the arcuate arteries provide an earlier 
signal of impending fetal compromise than any other known 
parameters for fetal surveillance. 
2) UMBLICAL ARTERY : 
 This vessel this visible in ultrasound at 6 to 7 weeks of gestation. 
 The vessel does not show diastolic flow till 10 weeks of gestation, 
implying a high resistance channel due to incompetence villous 
maturation. 
 Between 10 to 14 weeks the diastolic flow is inconsistent. 
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SITES OF INSONATION OF UTERINE ARTERY : 
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Schulman and colleagues stated that in non pregnant state there is 
rapid rise and fall in uterine artery flow velocity during systole and a notch 
in descending wave form in early diastole (32). During pregnancy there is 
increase in uterine artery compliance between 8 to 16 weeks , which 
continued to lesser extent until 26 weeks gestation. This physiologic change 
in compliance resulted in loss of diastolic notch between 20 and 26 weeks. 
Jurkovic and Juaniaux found similar changes in resistance index and 
pulsatility index of uterine artery (33). 
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UTERINE ARTERY DOPPLER WITH PROTODIASTOLIC NOTCH: 
 
DISAPPEARANCE OD DIASTOLIC NOTCH AFTER 24 WEEKS: 
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CRITERIA FOR ABNORMAL TEST (34): 
 Elevation of resistance index, pulsatility index and persistence of 
uterine artery notch to detect presence of increased uteroplacental 
vascular resistance. 
 PI of 95 percentile is the cut off. 
 Uterine artery Doppler has a false positive rate of 25 % and able to 
identify 67.5% who develop preeclampsia . 
 Recently Pulsatility index and uterine artery notch is used to predict 
preeclampsia. 
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MATERIALS AND METHODOLOGY 
DESIGN, METHODOLOGY AND TECHNIQUE : 
Study will be conducted in 100 women with high risk pregnancies 
including women with family history and previous history of pregnancy 
induced hypertension, eclampsia, antepartum haemorrhage (abruption), twin 
pregnancies, elderly primigravida, grand multipara, previous bad obstetric 
history . 
DESIGN : Prospective study 
INCLUSION CRITERIA : 
     All antenatal cases more than 20 weeks of gestation having increased risk 
of developing pregnancy induced hypertension . 
EXCLUSION CRITERIA : 
1)  All antenatal cases less than 20 weeks of gestation. 
2)  All antenatal cases with chronic hypertension. 
3)  Patients who cannot be followed up. 
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OBSERVATION AND RESULTS 
The following few pages are the tables which give a descriptive 
analysis of age, parity distribution of the 100 patients taken into this study. It 
also includes positive family history, pre pregnancy BMI, notching in 
uterine artery Doppler and pulsatility index for the patients included in this 
study. 
TABLE –1 
DISTRIBUTION OF PATIENTS ACCORDING TO AGE 
Age Frequency Percent 
Less than 20 yrs 26 26.5 
20 - 30 yrs 40 40.8 
30 - 35 yrs 19 19.4 
More than 35 yrs 13 13.3 
Total 98 100.0 
54 
 
                               
GRAPH-1 
DISTRIBUTION OF PATIENTS ACCORDING TO AGE 
 
According to the above table and graph maximum number of patients in this 
study group belongs to age group 20 to 30 years (40%). 13 % of patients 
belong to >35 years age group . 
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TABLE -2 
DISTRIBUTION OF PATIENTS ACCORDING TO PARITY 
Parity 
 Frequency Percent 
First pregnancy 31 31.6 
Second pregnancy 46 46.9 
Third pregnancy & more 21 21.4 
Total 98 100.0 
 
         31 patients in this study are primi gravid , 46 patients are second gravid 
and 21 patients belong to third gravid or more .     
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TABLE -3 
DISTRIBUTION OF PTS ACCORDING TO PREVIOUS H/O OF PIH. 
Previous history of PIH 
 Frequency Percent 
Yes 21 21.4 
No 77 78.6 
Total 98 100.0 
 
21 patients have positive history of PIH during their previous 
pregnancy. 
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TABLE 4 
DISTRIBUTION OF PTS ACCORDING TO POSITIVE FAMILY 
HISTORY. 
Family history of PIH 
 Frequency Percent 
Yes 15 15.3 
No 83 84.7 
Total 98 100.0 
 
15 % of the patients have positive family history, that is their mother/sisters 
had similar complaints during their pregnancy. 
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TABLE 5 
DISTRIBUTION OF PTS ACCORDING TO NOTCHING IN 2 nd 
SCAN 
Notching in second scan Frequency Percent 
Yes 36 36.7 
No 62 63.3 
Total 98 100.0 
 
Persistance of diastolic Notching in second scan done after 24 weeks 
is more important in prediction of pregnancy induced hypertension. It has 
higher sensitivity than specificity. Hence it can be used as a screening test in 
PIH prediction. 
 
 
 
 
59 
 
TABLE 6 
DISTRIBUTION OF PATIETNS ACCORDING TO PULSATILITY 
INDEX 
                         Pulsatility 
Index Frequency Percent 
> 90th percentile 36 36.7 
Normal 62 63.3 
Total 98 100.0 
 
Pulsatility index is an emerging tool in the prediction of pregnancy 
induced hypertension. Index more than 90 th percentile is more significant in 
detection. It has both sensitivity and specificity in prediction of PIH. Patients 
in table 5 and 6 was given more importance and was followed for, to detect 
whether the patient is developing PIN or not. 
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TABLE 7 
DISTRIBUTION OF PATIENTS ACCORDING TO PRE 
PREGNANCY BMI 
             Pre pregnancy BMI Frequency Percent 
>30 17 17.3 
<30 81 82.7 
Total 98 100.0 
   
From many studies it was found that, Increased pre pregnancy BMI also had 
increased risk for developing PIH. So, this factor is also included in this 
study. 
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TABLE 8 
DEVELOPMENT OF PIH 
Development of PIH Frequency Percent 
Yes 36 36.7 
No 62 63.3 
Total 98 100.0 
 
Out of 100 patients in this study, 36 patients developed pregnancy induced 
hypertension. Results of the above study is analysed as follows. 
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TABLE 9 
DISTRIBUTION OF PIH ACCORDING TO AGE 
Age * 
Development of PIH 
 
Development of PIH 
Total 
Yes No 
Less than 20 yrs No 22 4 26 
% 61.1% 6.5% 26.5% 
20 - 30 yrs No 5 35 40 
% 13.9% 56.5% 40.8% 
30 - 35 yrs No 5 14 19 
% 13.9% 22.6% 19.4% 
More than 35 yrs No 4 9 13 
% 11.1% 14.5% 13.3% 
Total No 36 62 98 
% 100.0% 100.0% 100.0% 
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                                                    GRAPH 2 
DISTRIBUTION OF PIH ACCORDING TO AGE 
 
 
From the above table and graph it is found that 22% of patients less than 20 
yrs of age developed PIH. PIH is common in both extremes of age that is 
<20 yrs age and > 30 yrs of age. 
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TABLE 10 
DISTRIBUTION OF PIH ACCORDING TO PARITY 
 
Parity *  
Development of PIH 
Development of PIH 
Total Yes No 
First pregnancy No 10 21 31 
% 27.8% 33.9% 31.6% 
Second pregnancy No 23 23 46 
% 63.9% 37.1% 46.9% 
Third pregnancy & more No 3 18 21 
% 8.3% 29.0% 21.4% 
Total No 36 62 98 
% 100.0% 100.0% 100.0% 
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GRAPH 3 
DISTRIBUTION OF PIH ACCORDING TO PARITY 
 
X axis – parity, Y axis –number of patients 
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TABLE 11 
DISTRIBUTION OF PIH ACCORDING TO PREVIOUS HISTORY 
OF PIH 
Previous history of PIH * 
Development of PIH 
Development of PIH 
Total Yes No 
Yes No 14 7 21 
% 38.9% 11.3% 21.4% 
No No 22 55 77 
% 61.1% 88.7% 78.6% 
Total No 36 62 98 
% 100.0% 100.0% 100.0% 
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GRAPH 4 
DISTRIBUTION OF PIH ACCORDING TO PREVIOUS HISTORY 
OF PIH 
 
X axis- number of patients,Y axis-development of PIH. 
Among the patients who developed PIH 14 % have previous history of PIH 
in previous pregnancy. 
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TABLE 12 
FAMILY HISTORY AND PIH 
 
Family history of PIH *  
Development of PIH 
 
Development of PIH 
Total 
Yes No 
Yes 
No 9 6 15 
% 25.0% 9.7% 15.3% 
No 
No 27 56 83 
% 75.0% 90.3% 84.7% 
Total 
No 36 62 98 
% 100.0% 100.0% 100.0% 
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GRAPH 5 
FAMILY HISTORY AND PIH 
 
X axis- number of patients with family history, Y axis-development of PIH 
Among patients who developed PIH 9% patients have positive family 
history of PIH. 
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TABLE 13 
PERSISTANCE OF NOTCHING AND PIH 
 
Notching in second scan *  
Development of PIH 
Development of PIH 
Total Yes No 
Yes 
No 36 0 36 
% 100.0% .0% 36.7% 
No 
No 0 62 62 
% .0% 100.0% 63.3% 
Total 
No 36 62 98 
% 100.0% 100.0% 100.0% 
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GRAPH 6 
                            PERSISTANCE OF NOTCHING AND PIH 
 
X axis- development of PIH, Y axis- number of patients who develop PIH or 
not .36 patients among 100 patients develop PIH. Among 36 patients nearly 
all patients had persistence of diastolic notching in the second scan done. 
                                                            
 
0
10
20
30
40
50
60
70
Yes No
36
00
62
Development of PIH Yes
Development of PIH No
72 
 
TABLE 14 
PULSATILITY INDEX AND DEVELOPMENT OF PIH 
Pulsatility Index *  
Development of PIH 
Development of PIH 
Total 
Yes No 
> 90th percentile 
No 36 0 36 
% 100.0% .0% 36.7% 
Normal 
No 0 62 62 
% .0% 100.0% 63.3% 
Total 
No 36 62 98 
% 100.0% 100.0% 100.0% 
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GRAPH 7 
PULSATILITY INDEX AND DEVELOPMENT OF PIH 
 
 
          X axis- Pulsatility index value, Y axis – number of patients who 
develop PIH 
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TABLE 15 
DISTRIBUTION OF PIH AND PRE PREGNANCY BMI 
Pre pregnancy BMI *  
Development of PIH 
 
Development of PIH 
Total 
Yes No 
>30 
No 12 5 17 
% 33.3% 8.1% 17.3% 
<30 
No 24 57 81 
% 66.7% 91.9% 82.7% 
Total 
No 36 62 98 
% 100.0% 100.0% 100.0% 
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GRAPH 8 
DISTRIBUTION OF PIH AND PRE PREGNANCY BMI 
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DISCUSSION 
Uteroplacental circulation  by  Doppler ultrasound was first studied by 
Campbel et al (35). Most of the studies are based on alterations in uterine 
artery wave form, mainly the presence of bilateral diastolic notching with 
the onset of gestational complications. Our study is based on the fact that 
uterine artery Doppler – bilateral diatolic notching and pulsatility index can 
be used as a screening test, before the disease actually sets in . 
             Our  study is a prospective study, testing the validity of the uterine 
artery Doppler for the prediction of pregnancy induced hypertension. This 
study also to determine the behavior of the impedence indices in the uterine 
arteries during the second half of the pregnancy. Patients are longitudinally 
followed up till the resolution of their pregnancy. 
     Indices ,are commonly utilized in Doppler studies are Resistance index, 
pulsatility index and notching which are widely accepted parameters for 
analysis(36).Some researchers recommend the use of pulsatility index as a 
better quantifier in cases of absent end diastolic velocity and in cases with 
reverse diastolic flow. In our study we use twp indices. One is  persistence 
of uterine artery diastolic notching and the other is pulsatility index. 
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             Decrease in Doppler indices with progress of pregnancy, reflects 
that there is adequate trophoblastic invasion and consequential 
multiplication of villi system, resulting in continuous reduction of 
impedance to the blood flow in uterine arteries. Results of our study is 
similar to results obtained by Thaler et al (37) and Kurjak et al (38). Thaler             
et al(37) also demonstrated that increase in blood volume in uterine artery 
with pregnancy development, with this increase being more pronounced as 
from 20 th week . 
           Kurdiet et al (39) and Montenegro et al (40) observed that pulsatility 
index was higher in patients who developed Pregnancy induced hypertension 
and method is useful for the prediction of such complications. 
         The profile of uterine artery floe velocity is studied. A wave with high 
systolic peak, a prominent prodiastolic notch and low end diastolic flow is a 
normal uterine artery profile during first half of the pregnancy. Because of 
the implantation and the development of placenta, uterine artery circulation 
changes from low flow with high resistance to high flow with low resistance. 
This makes the proto diastolic notch in the uterine artery to disappear around 
24 to 26 weeks of pregnancy. 
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              The Doppler study of the uterine arteries are considered abnormal 
in persistence of diastolic notch in the flow velocity wave forms or increased 
value of indices after 20 weeks – both denotes increased resistance to the 
flow(41). 
                      In our present study maximum number of patients  belongs to 
age group 20 to 30 years (40%). 13 % of the patients belong to > 35 years 
age group. In authour’s study (HAYES EJ et al ) majority of the patients 
belong to age group 20 to 35 years, as our study mainly involves 
reproductive age group. 
        In our study among patients who develop PIH, 22 patients belong to 
age group < 20 years, 5 patients belong to 30 to 35 years. In study done by 
CAMPBELL et al (42) 28 % patients belong to teenage group, 32 % belong 
to age group 20 to 30 years. From this results, it is shown that PIH more 
prevalent among teenage population. PIH is common in both extremes of 
age group. 
      In our study, among patients who develop PIH, 10 patients are 
primigravida, 23 patients are second gravid and 3 patients are third gravid. 
In author’s study (CAMPBELL et al) 36 % who develop PIH are primi 
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gravid and 17 % are third gravida or more. PIH is more common in primi 
gravid. There is increased incidence with new paternity. 
           In our study among patients who develop PIH, 14 % have positive 
previous history in their first pregnancy.  
In author’s study (BEWLEY et al )43 Only 8 % patients have 
previous history of PIH in their first pregnancy. From this study we can 
conclude that, if a patient has previous history of PIH, she is having more 
risk of developing same complication in present pregnancy also. 
            In our study 9 patients with positive family history of  PIH  develop 
pregnancy induced hypertension in present pregnancy. VALENSISE et al 44 
Quoted that 2 % population of his study have positive family history develop 
PIH. As genetic predisposition of PIH is under research, it is important to 
elicit a positive family history. 
            In our study 36 patient out of 100 patients develop have diastolic 
notching develop PIH. Bilateral uterine artery notching have sensitivity of 
98.6% and specificity of 86.2%. Pulsatility index has sensitivity of 85.5% 
and negative predictive value of 98.2%. 
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SCREENING FOR PIH BY UTERINE ARTERY DOPPLER 
NOTCHING 
 JACOBSON  
et al 
CAMPBELL  
et al 
Our study 
GEST AGE 18-20 WEEKS >24 WEEKS >24 WEEKS 
PATIENTS COUNT 60 126 100 
PREVALENCE 44% 41% 36% 
SENSITIVITY 96% 98% 98.6% 
SPECIFICITY 73% 89% 86.2% 
 
From the above study uterine artery notching can be used as a screening test 
for the early prediction of pregnancy induced hypertension. 
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CONCLUSION 
 Doppler study should be included in routine antenatal care given in 
the hospital. 
 Uterine artery indices such as Bilateral notching and Pulsatility index 
can be used as a predictor of pregnancy induced hypertension. 
 Early prediction of pregnancy induced hypertension helps in early 
intervention and prevention of morbidity and mortality. 
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SUMMARY 
1) 40% of the patients in this study belong to age group 20 to 30 yrs of 
age. 
2)  31 patients in this study are primi garvida, 46 patients are second 
gravid and 21 patients are third gravid or more. 
3)  21 patients have positive previous history of PIH. 
4)  15 patients who develop PIH have positive family history of 
pregnancy induced hypertension. 
5)  Combination of both uterine artery diastolic notching and pulsatility 
index have more sensitivity and specificity than taking single factor 
alone. 
6)  22 % of patients < 20 years develop pregnancy induced hypertension. 
7)  Among patients who develop PIH 14% have previous history of PIH. 
8)  Among patients who develop PIH 9% have positive family history of 
PIH. 
9)  36 patients among 100 patients taken into this study develop PIH. 
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ANNEXURE 1 
PROFORMA 
NAME   : 
AGE    : 
OCCUPATION  : 
HOSPITAL NO  : 
ADDRESS   : 
CHIEF COMPLAINTS  : 
OBSTETRIC HISTORY  : 
History of preeclampsia in previous pregnancy is asked for. 
PAST HISTORY   : 
Associated risk factors are asked for. 
FAMILY HISTORY  : 
History of pregnancy induced hypertension among family members. 
EXAMINATION OF PATIENT : 
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General condition :                      Nutritional status : 
Anaemia/pedal edema/clubbing/lymphadenopathy 
CVS     : 
RS     : 
Pulse rate    : 
Blood pressure   : 
PER ABDOMEN    : 
FIRST SCAN REPORT  : 
SECOND SCAN REPORT  : 
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CONSENT FORM 
Xg;g[jy; gotk; 
 
bgah;   : 
ghypdk;   : 
 taJ   : 
Kfthp   : 
 
muR nfhit kUj;Jtf; fy;Y}hpapy; kfg;ngW kUj;Jt Jiwapy; 
gl;l gapYk; khztp mth;fs; nkw;bfhs;Sk; "fUtpy; cs;s 
FHe;ijf;F bry;Yk; uj;j Xl;lk;" Fwpj;j Ma;tpy; bra;Kiw kw;Wk; 
midj;J tptu';fisa[k; nfl;Lf; bfhz;L vdJ re;njf';fis 
bjspt[g;gLj;jpf; bfhz;nld; vd;gij bjhptpj;Jf; bfhs;fpnwd;. 
 
ehd; ,e;j Ma;tpy; KG rk;kjj;Jld;/ Ra rpe;jida[lDk; fye;J 
bfhs;s rk;kjpf;fpnwd;. 
 
,e;j Ma;tpy; vd;Dila midj;J tpgu';fs; ghJfhf;fg;gLtJld; 
,jd; Kot[fs; Ma;tpjHpy; btspaplg;gLtjpy; Ml;nrgid ,y;iy 
vd;gij bjhptpj;Jf; bfhs;fpnwd;. ve;j neuj;jpYk; ,e;j Ma;tpypUe;J 
ehd; tpyfpf; bfhs;s vdf;F chpik cz;L vd;gija[k; mwpntd;. 
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KEY TO MASTER CHART 
AGE   :  <20YRS – 1 
             20 TO 30 YRS -2 
            30 TO 35 YRS – 3 
             > 35 YRS -4 
PARITY  :  FIRST PREGNANCY -1 
                  SECOND PREGNANCY -2 
                   THIRD PREGNANCY AND MORE -3 
PREVIOUS HISTORY OF PIH  :  YES -1 
                                                      NO-2 
FAMILY HISTORY OF PIH   :  YES-1 
                                                 NO-2 
NOTCHING IN FIRST SCAN   :  YES -1 
                                                    NO-2 
NOTCHING IN 2ND SCAN   : YES-1 
                                                NO-2 
PULSATILITY INDEX    :  >90TH PERCENTILE -1 
                                         NORMAL -2 
URINE ALBUMIN    :  POSITIVE -1 
                                     NEGATIVE-2 
DEVELOPMENT OF PIH   : YES-1 
                                              NO-2 
PRE PREGNANCY BMI   : >30-1 
                                           <30-2 
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MASTER CHART 
 
S.no AGE PARITY 
PREV 
H/O 
FAMILY 
 H/O 
ASSO  
RISK FAC 
PREPREG 
BMI 
NOTCHING 
 IN 1ST 
SCAN 
NOTCHING 
 IN 2ND 
SCAN 
PULS. 
INDEX PIH URINE ALB 
1 1 1 2 2   2 1 2     2 
2 3 3 1 1 GDM 1 1 1 1 1 1 
3 4 1 2 2   2 1 2     2 
4 1 2 1 2   2 1 1 1 1 2 
5 3 3 2 2   2 1 2     2 
6 1 1 2 2   2 1 2     2 
7 2 2 1 2 HYPOTHYROID 1 1 1 1 1 1 
8 3 1 2 2   2 1 2     2 
9 2 3 1 2   2 1 2     2 
10 1 1 2 1   2 1 1 1 1 2 
11 2 3 2 2   2 1 2     2 
12 3 1 2 2   2 1 1 1 1 2 
13 2 3 2 2   2 1 2     2 
14 1 1 2 2 HYPOTHYROID 1 1 1 1 1 1 
15 2 2 1 2   2 1 1 1 1 2 
16 3 1 2 2   2 1 2     2 
17 2 1 2 2   1 1 2     2 
18 1 2 2 2   2 1 1 1 1 1 
19 3 3 1 1   2 1 1 1 1 2 
20 4 2 2 2   1 1 2     2 
21 3 1 2 2   2 1 2     2 
22 1 2 1 2   2 1 1 1 1 1 
23 4 1 2 2   1 1 2     2 
24 3 3 2 2   2 1 2     2 
25 1 1 2 1 HYPOTHYROID 2 1 1 1 1 2 
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26 2 1 2 2   2 1 2     2 
27 4 2 1 2   1 1 2     2 
28 1 2 2 1   2 1 1 1 1 2 
29 2 1 2 2   2 1 2     2 
30 4 3 2 2   1 1 2     2 
31 1 2 1 1   2 1 1 1 1 2 
32 2 1 2 2   2 1 2     2 
33 3 1 2 2   2 1 2     2 
34 2 1 2 2   2 1 2     2 
35 4 2 1 2 GDM 1 1 1 1 1 2 
36 1 2 2 1 HYPOTHYROID 2 1 1 1 1 1 
37 2 1 2 2   2 1 2     2 
38 3 3 1 2   2 1 2     2 
39 1 1 2 1   2 1 1 1 1 2 
40 2 2 1 2   2 1 2     2 
41 2 2 2 2   2 1 2     2 
42 3 3 2 2   2 1 2     2 
43 1 2 1 1   2 1 1 1 1 2 
45 2 2 2 2   2 1 2     2 
46 3 3 2 2 HYPOTHYROID 2 1 2     2 
47 2 1 2 1   2 1 2     2 
48 1 2 2 2   2 1 1 1 1 1 
49 2 2 1 2   2 1 2     2 
50 3 3 2 1   2 1 2     2 
51 2 2 1 2 HYPOTHYROID 2 1 2     2 
52 1 1 2 2 GDM 2 1 2     2 
53 2 2 2 2   2 1 2     2 
54 4 2 1 2   2 1 2     2 
55 2 2 2 2   2 1 2     2 
56 1 1 2 2 HYPOTHYROID 1 1 1 1 1 1 
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57 2 2 2 2   2 1 2     2 
58 4 2 2 1   2 1 2     2 
59 2 1 2 2   2 1 2     2 
60 1 2 1 2   2 1 1 1 1 2 
61 2 2 2 2   2 1 2     2 
62 4 1 2 2   2 1 1 1 1 1 
63 3 3 2 2   2 1 2     2 
64 2 2 2 2 GDM 2 1 2     2 
65 1 2 2 2   1 1 1 1 1 2 
66 2 1 2 2   2 1 2     2 
67 4 2 1 2 GDM 2 1 1 1 1 1 
68 3 3 2 2   2 1 2     2 
69 1 2 2 2   1 1 1 1 1 2 
70 2 1 2 2   2 1 2     2 
71 2 2 2 1   2 1 2     2 
72 4 2 2 2   2 1 1 1 1 2 
73 2 2 2 2   2 1 2     2 
74 1 1 2 2   1 1 1 1 1 1 
75 2 2 2 2   2 1 2     2 
76 2 2 1 2   2 1 1 1 1 2 
78 3 3 2 2   2 1 2     2 
79 1 1 2 2   2 1 1 1 1 2 
80 4 2 2 2   2 1 2     2 
81 2 2 1 2   1 1 1 1 1 2 
82 3 1 2 2   2 1 2     2 
83 2 2 2 2   2 1 2     2 
84 1 2 2 2 GDM 2 1 1 1 1 2 
85 2 3 2 2   2 1 2     2 
86 3 1 2 2   1 1 1 1 1 1 
87 2 2 2 2   2 1 2     2 
98 
 
88 1 2 2 2 HYPOTHYROID 2 1 1 1 1 1 
89 2 3 2 2   2 1 2     2 
90 4 1 2 2   2 1 2     2 
91 2 2 2 1   2 1 2     2 
92 1 2 1 2   2 1 1 1 1 1 
93 2 3 2 2   2 1 2     2 
94 2 3 2 2   2 1 2     2 
95 2 2 2 2   1 1 1 1 1 2 
96 1 2 2 2   2 1 2     2 
97 2 3 2 1   2 1 2     2 
98 3 3 2 2   2 1 1 1 1 2 
99 2 2 2 2   2 1 2     2 
100 1 2 2 2 GDM 1 1 1 1 1 1 
 
 
 
 
 
